When was Myolex founded?

Myolex was founded in 2016 and raised its 1st funding round 1 year after it was founded.

Where is Myolex located?

Myolex is headquartered in Boston, United States.

How many employees does Myolex have?

As of Aug 31, 2026, the latest employee count at Myolex is 7.

Is Myolex a funded company?

Myolex is a funded company, having raised an undisclosed amount across 8 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Sep 20, 2017.

When was the latest funding round of Myolex?

Myolex's latest funding was a $***** Grant (prize money) round on Dec 29, 2025, with participation from 1 investor. Its primary sector is Orthopedics. In United States, the Orthopedics sector has seen $2.48B in funding in 2026 to date.

Where does Myolex rank among its competitors?

Myolex ranks 36th amongst 132 active competitors, of which 31 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Myolex, which secured $1.75M in Dec, 2025.

Who are the top competitors of Myolex?

Myolex's top competitors include Treace Medical Concepts, Bioretec and Paragon 28. Among them, Myolex secured the most recent funding round in December, 2025.

Myolex - 2026 Company Profile, Team, Funding & Competitors

Myolex is a funded company based in Boston (United States), founded in 2016. It operates as an Innovating muscle assessment technology for neuromuscular disorders and muscle wasting diseases. Myolex has raised an undisclosed amount in funding. The company has 132 active competitors, including 31 funded and 32 that have exited. Its top competitors include companies like Treace Medical Concepts, Bioretec and Paragon 28.

Company Details

Innovating muscle assessment technology for neuromuscular disorders and muscle wasting diseases. They are dedicated to building clinical gold standards for measuring muscle wasting and its treatment impact. The company develops comprehensive, painless, and portable solutions for assessing muscle quality, even at home. Their technology aims to aid in the diagnosis, prognosis, and treatment of neuromuscular and musculoskeletal diseases. They offer quantitative data on functional capability while the muscle remains at rest, using a portable, non-invasive device. Their electrical impedance myography (EIM) technology measures changes in electrical impedance to assess muscle composition and micro infrastructure. This technology has the potential to reduce clinical trial sample sizes, enable standardized data collection, and serve as a powerful biomarker. Their mission is to comprehensively assess and display changes in skeletal muscle composition and micro infrastructure, supporting clinicians, scientists, caregivers, and patients. The company's technology holds potential for early disease diagnosis and could replace expensive muscle measurement devices.

Website: www.myolex.com/
Email ID: *****@myolex.com
Phone Number: +1 **********

Key Metrics

Founded Year

2016

Location

Boston, United States

Stage

Funding Raised

Latest Funding Round

Grant (prize money), Dec 29, 2025, $*****

Investors

Nautilus Venture Partners & 2 more

Ranked

36^th among 132 active competitors

Employee Count

7 as on Aug 31, 2026

Similar Companies

Treace Medical Concepts & 180 more

View Myolex's full profile

Myolex has raised funding over 8 rounds. Its first funding round was on Sep 20, 2017. Its latest funding round was a Grant (prize money) round on Dec 29, 2025 for $*****. 1 investor participated in its latest round. Myolex has 3 institutional investors.

Here is the list of recent funding rounds of Myolex:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Dec 29, 2025	3314232	Grant (prize money)	6755227	9676920	1960621	2453252
Aug 28, 2025	9950806	Grant (prize money)	5970956	2793291	4874071	HHS
May 13, 2025	6820929	Grant (prize money)	1102370	3839682	9139041	HHS

Access funding benchmarks and valuations. Sign up today!

View details of Myolex's funding rounds and investors

Myolex's employee count trend

Myolex has 7 employees as of Aug 26. Here is Myolex's employee count trend over the years:

Uncover Myolex's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Myolex include Treace Medical Concepts, Bioretec and Paragon 28. Here is the list of Top 10 competitors of Myolex, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Treace Medical Concepts 2013, Ponte Vedra Beach (United States), Public	A three-plane Hallux Valgus correction system	$15M	CRG, SVB	61/100
2nd	Bioretec 1985, Tampere (Finland), Public	Provider of bioabsorbable, bioactive and drug-releasing surgical implants	$8.58M	Springvest, Innovestor & 3 others	58/100
3rd	Paragon 28 2010, Englewood (United States), Acquired	Provider of foot and ankle surgery devices	$200K	MVM, Oceanic Partners & 2 others	57/100
4th	AAP Implantate 1990, Berlin (Germany), Acquired	Manufacturer of implants and technologies for trauma and antibacterial solutions	-	Bmp Ventures, Ramphastos Investments	55/100
5th	Atreon Orthopedics 2016, Hilliard (United States), Series A	Innovating orthopedics with advanced biologic solutions for musculoskeletal healing	$5.42M	Proton Enterprises, Monte Carlo Capital & 1 others	54/100
6th	Medartis 1997, Basel (Switzerland), Public	Fixation systems for orthopedic procedures	-	Endeavour Vision	50/100
7th	Synoste 2012, Espoo (Finland), Acquired	Limb lengthening device	$11M	Evonik Venture Capital, Innovestor & 9 others	48/100
8th	Biedermann 1916, Villingen Schwenningen (Germany), Unfunded	Implants for spine and trauma	-	-	48/100
9th	Nextremity Solutions 2006, Warsaw (United States), Acquired	Developer of extremity musculoskeletal orthopedic products	$22.1M	Rockport Venture Partners	46/100
10th	Small Bone Innovations 2004, Morrisville (United States), Acquired	Suite of orthopedic products for small bones and joints	$181M	NGN Capital, 3i Group & 11 others	45/100
36th	Myolex 2016, Boston (United States), Funding Raised	Innovating muscle assessment technology for neuromuscular disorders and muscle wasting diseases	-	Nautilus Venture Partners, Caerus Ventures ... & 1 others	33/100